Stem cell-derived conditioned medium, the liquid that remains after cells are cultured, reduced PAH signs in rats and cells, ...

Gossamer Bio has begun the process of acquiring Respira Therapeutics and its lead on-demand PH treatment candidate, RT234.

Columnist Jolie Lizana attended the Pulmonary Hypertension Association's (PHA) PHPN Symposium, which discussed PH research.

Tenax said the European Patent Office will grant it a patent protecting the use of levosimendan to treat PH-HFpEF in Europe.

Higher pulmonary arterial pressure in pregnant women with PH was linked to longer hospitalizations, and ICU admission, in a ...

Underweight infants with PH have a high risk of developing retinopathy of prematurity, a leading cause of childhood blindness ...

Allrock raised $50 million to support the launch of a Phase 2a clinical trial testing PH treatment ROC-101 in people with PAH ...

As a PH patient and transplant recipient, columnist Anna Jeter relies on her care team when it comes to vaccine recommendations.

Pulmonary hypertension (PH) is a rare but life-threatening lung disorder that damages the vessels responsible for transporting blood from the heart to the lungs, known as the pulmonary arteries. The ...

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...